Illumina 2026-01-08 Exclusive: Illumina hires former NHGRI director as chief medical officer - Endpoints News
Endpoints News 2026-01-08 FDA staff cuts mostly didn't impact new drug review timelines, analysis finds
Endpoints News 2026-01-08 Ollin’s drug clears retinal disease better than Roche’s Vabysmo in Phase 1b trial
Endpoints News 2026-01-08 French biotech Enodia gets €20.7M aided by Pfizer for protein degrader work
Endpoints News 2026-01-08 Charles Fuchs leaves Roche to steer ADC pipeline at Tubulis shortly after $401M Series C
Endpoints News 2026-01-07 Immuneering’s pancreatic cancer pill continues to beat standard care, updated first line data show